Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke
- PMID: 21682695
- DOI: 10.1111/j.1600-0404.2011.01555.x
Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke
Retraction in
-
Retraction: 'Sunlight exposure is important for preventing hip fractures in patients with Alzheimer's disease, Parkinson's disease, or stroke' by J. Iwamoto, T. Takeda and H. Matsumoto.Acta Neurol Scand. 2018 Jun;137(6):630. doi: 10.1111/ane.12940. Epub 2018 Mar 30. Acta Neurol Scand. 2018. PMID: 29732540
Abstract
Objectives: Hypovitaminosis D as a result of malnutrition or sunlight deprivation, increased bone resorption, low bone mineral density (BMD), or an increased risk of falls may contribute to an increased risk of hip fractures in patients with neurological diseases, including Alzheimer's disease, Parkinson's disease, and stroke. The purpose of this study was to clarify the efficacy of sunlight exposure for reducing the risk of hip fractures in patients with such neurological diseases.
Methods: The English literature was searched using PubMed, and randomized controlled trials evaluating the efficacy of sunlight exposure for reducing the risk of hip fractures in patients with Alzheimer's disease, Parkinson's disease, and stroke were identified. The relative risk and the 95% confidence interval were calculated for individual randomized controlled trials, and a pooled data analysis (meta-analysis) was performed.
Results: Three randomized controlled trials were identified. Sunlight exposure improved hypovitaminosis D and increased the BMD. The relative risk (95% confidence interval) of hip fractures was 0.22 (0.05, 1.01) for Alzheimer's disease, 0.27 (0.08, 0.96) for Parkinson's disease, and 0.17 (0.02, 1.36) for stroke. The relative risk (95% confidence interval) calculated for the pooled data analysis was 0.23 (0.10, 0.56) (P = 0.0012), suggesting a significant risk reduction rate of 77%.
Conclusion: The present meta-analysis added additional evidence indicating the efficacy of sunlight exposure for reducing the risk of hip fractures in patients with Alzheimer's disease, Parkinson's disease, and stroke.
© 2011 John Wiley & Sons A/S.
Comment in
-
Inaccurate retraction notice for meta-analysis by Iwamoto et al.Acta Neurol Scand. 2018 Sep;138(3):263. doi: 10.1111/ane.12962. Acta Neurol Scand. 2018. PMID: 30133693 No abstract available.
Similar articles
-
Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease.Aging Clin Exp Res. 2009 Aug-Oct;21(4-5):277-81. doi: 10.1007/BF03324916. Aging Clin Exp Res. 2009. PMID: 19959915
-
Efficacy of risedronate against hip fracture in patients with neurological diseases: a meta-analysis of randomized controlled trials.Curr Med Res Opin. 2008 May;24(5):1379-84. doi: 10.1185/030079908x297321. Epub 2008 Apr 1. Curr Med Res Opin. 2008. Retraction in: Curr Med Res Opin. 2017 Jun;33(6):1179. doi: 10.1080/03007995.2017.1300004. PMID: 18384711 Retracted. Review.
-
Strategy for prevention of hip fractures in patients with Parkinson's disease.World J Orthop. 2012 Sep 18;3(9):137-41. doi: 10.5312/wjo.v3.i9.137. World J Orthop. 2012. Retraction in: World J Orthop. 2017 Oct 18;8(10):814. doi: 10.5312/wjo.v8.i10.814. PMID: 23173109 Free PMC article. Retracted.
-
Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in Parkinson's disease.Parkinsonism Relat Disord. 2011 Jan;17(1):22-6. doi: 10.1016/j.parkreldis.2010.10.008. Epub 2010 Nov 2. Parkinsonism Relat Disord. 2011. Retraction in: Parkinsonism Relat Disord. 2016 Jul;28:171. doi: 10.1016/j.parkreldis.2016.05.027. PMID: 21050796 Retracted. Clinical Trial.
-
Efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases: meta-analysis of three randomized, controlled trials.Clin Drug Investig. 2009;29(7):471-479. doi: 10.2165/00044011-200929070-00005. Clin Drug Investig. 2009. Retraction in: Clin Drug Investig. 2018 May;38(5):479. doi: 10.1007/s40261-018-0643-3. PMID: 19499964 Retracted. Review.
Cited by
-
Bone mineral density in osteoporotic patients with pyogenic vertebral osteomyelitis: effect of early versus late treatment for osteoporosis.Osteoporos Int. 2018 Dec;29(12):2761-2770. doi: 10.1007/s00198-018-4695-2. Epub 2018 Sep 17. Osteoporos Int. 2018. PMID: 30225674
-
Teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw in an elderly Japanese woman with severe osteoporosis.Clin Drug Investig. 2012 Aug 1;32(8):547-53. doi: 10.1007/BF03261908. Clin Drug Investig. 2012. PMID: 22734599
-
Alzheimer's Disease is an Important Risk Factor of Fractures: a Meta-analysis of Cohort Studies.Mol Neurobiol. 2017 Jul;54(5):3230-3235. doi: 10.1007/s12035-016-9841-2. Epub 2016 Apr 12. Mol Neurobiol. 2017. PMID: 27072352
-
Poststroke hip fracture: prevalence, clinical characteristics, mineral-bone metabolism, outcomes, and gaps in prevention.Stroke Res Treat. 2013;2013:641943. doi: 10.1155/2013/641943. Epub 2013 Sep 25. Stroke Res Treat. 2013. PMID: 24187647 Free PMC article.
-
Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson's Disease.Nutrients. 2016 Mar 4;8(3):142. doi: 10.3390/nu8030142. Nutrients. 2016. PMID: 26959053 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical